8.82
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ra Medical Systems Inc | RMED | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 8.82 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.82 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 8.82 | USD |
Ra Medical Systems Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 25.75M | 2.92M | 2.89M | $ 7.20M | $ - | -108.00 | -0.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 678.88k | 22.90% |
Ra Medical Systems News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RMED Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.0% |
| 3 Months | 0.20 | 9.47 | 0.17 | 1.83 | 1,069,813 | 8.62 | 4,310.0% |
| 6 Months | 0.388 | 9.47 | 0.17 | 0.4332938 | 4,269,163 | 8.43 | 2,173.2% |
| 1 Year | 2.20 | 9.47 | 0.17 | 0.4745791 | 2,966,290 | 6.62 | 300.91% |
| 3 Years | 21.50 | 22.00 | 0.17 | 0.7257161 | 1,294,890 | -12.68 | -58.98% |
| 5 Years | 21.50 | 22.00 | 0.17 | 0.7257161 | 1,294,890 | -12.68 | -58.98% |
Ra Medical Systems Description
| Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The company's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. It operates in two segments namely the vascular segment and the dermatology segment. |
